These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19588357)

  • 21. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis.
    Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C
    Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
    Liu M; Wardlaw J
    Cochrane Database Syst Rev; 2000; (2):CD000514. PubMed ID: 10796381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism.
    Igneri LA; Hammer JM
    J Pharm Pract; 2020 Feb; 33(1):74-89. PubMed ID: 29673293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients.
    Tardy B; Venet C; Zeni F; Coudrot M; Guyomarc'h S; Mismetti P
    Thromb Res; 2009 Dec; 124(6):672-7. PubMed ID: 19493561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should thrombolytic therapy be used in patients with pulmonary embolism?
    Konstantinides S
    Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.
    Agnelli G; Becattini C; Kirschstein T
    Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
    Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA
    Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant treatment for subsegmental pulmonary embolism.
    Yoo HH; Nunes-Nogueira VS; Fortes Villas Boas PJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD010222. PubMed ID: 32030721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient versus inpatient treatment for acute pulmonary embolism.
    Yoo HH; Queluz TH; El Dib R
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010019. PubMed ID: 25411774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Sandercock PA; Counsell C; Tseng MC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant treatment for subsegmental pulmonary embolism.
    Yoo HH; Queluz TH; El Dib R
    Cochrane Database Syst Rev; 2016 Jan; (1):CD010222. PubMed ID: 26756331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of thrombolytic therapy to treat heparin-refractory pulmonary embolism in a menstruating patient.
    Koch AZ; Abubaker J; Barnett VT; Chan LN
    Pharmacotherapy; 2002 Jan; 22(1):118-22. PubMed ID: 11794423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombolytic therapy for submassive pulmonary embolism.
    Lankeit M; Konstantinides S
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):379-89. PubMed ID: 22959553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
    Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Milne AA; Gillespie WJ
    Cochrane Database Syst Rev; 2002; (4):CD000305. PubMed ID: 12519540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.